Various studies have demonstrated that targeting Skp2 in various cancer cells as well as in animal models resulted in the upregulation of p27 level that results into tumor shrinkage and apoptosis (Yokoi et al., 2003; Kudo et al., 2005; Lee and McCormick, 2005). The gene discussed is SKP2; the disease is cancer.